Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Cognitive impairment predicts worsening multiple sclerosis
- Author:
- Jeff Evans
News
Abatacept fails to provide benefit in relapsing-remitting MS
- Author:
- Jeff Evans
News
Abatacept autoinjector approved to treat rheumatoid arthritis
- Author:
- Jeff Evans
News
Focused-ultrasound device approved to treat essential tremor
- Author:
- Jeff Evans
The FDA approved a device that treats essential tremor using transcranial focused ultrasound to destroy MRI-identified pathologic areas of the...
Video
VIDEO: TNF inhibitors improved refractory skin disease in juvenile dermatomyositis
- Author:
- Jeff Evans
Key clinical point: TNF inhibitor treatment in patients with juvenile dermatomyositis may be beneficial for skin involvement that is refractory to...
Video
VIDEO: No major malformations ascribed to bisphosphonate use in pregnancy
- Author:
- Jeff Evans
Key clinical point: One of the largest controlled studies on pregnancy outcomes following bisphosphonate use found no increase in major...
Video
VIDEO: Romosozumab bested teriparatide in hip BMD transitioning from bisphosphonates
- Author:
- Jeff Evans
Key clinical point: Romosozumab raised total hip BMD to a significantly greater extent than did teriparatide after 12 months in postmenopausal...
News
Methotrexate in RA: Too low, too short, too few subcutaneous doses?
- Author:
- Jeff Evans
CHARLOTTE, N.C. – Methotrexate’s role as the mainstay drug of choice to treat rheumatoid arthritis has never been challenged, but questions...
News
After Inflectra’s approval, challenges remain for biosimilars
- Author:
- Jeff Evans
Now that the FDA has approved Inflectra as the first biosimilar version of Remicade, rheumatologists and patient advocacy groups are taking stock...
News
Endovascular thrombectomy procedure volume for stroke may not affect outcomes
- Author:
- Jeff Evans
Patient outcomes after endovascular mechanical thrombectomy for acute ischemic stroke do not appear to be worse at low- versus high-volume...
News
Women With Epilepsy Conceive at Normal Rate
- Author:
- Jeff Evans
Key clinical point: Women with epilepsy do not have lower ability to conceive. Major finding: 70% of women with epilepsy and 67% of healthy...
News
Women with epilepsy conceive at normal rate
- Author:
- Jeff Evans
VANCOUVER – Women with epilepsy have fertility rates comparable with healthy women in the general population, according to results from the first...
News
AAN updates botulinum toxin guidelines for most established uses
- Author:
- Jeff Evans
News
Patients suffer morbidity due to MS misdiagnosis
- Author:
- Jeff Evans
Key clinical point: Misapplication or misinterpretation of diagnostic criteria for multiple sclerosis can lead to misdiagnosis and potential...
News
Study details synovial features in RA remission and shift back to active disease
- Author:
- Jeff Evans
Key clinical point: There are histopathologic features in synovial tissue from patients with ultrasound-defined synovitis despite RA clinical...